{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:30:15Z","timestamp":1740162615038,"version":"3.37.3"},"reference-count":30,"publisher":"BMJ","issue":"2","funder":[{"DOI":"10.13039\/501100001787","name":"University of South Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009843","name":"South Australian Health and Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009843","id-type":"DOI","asserted-by":"publisher"}]},{"name":"South Australian Department of Health"},{"DOI":"10.13039\/501100000950","name":"Cancer Council SA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000950","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001787","name":"University of South Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009843","name":"South Australian Health and Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009843","id-type":"DOI","asserted-by":"publisher"}]},{"name":"South Australian Department of Health"},{"name":"Cancer Council SA"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2018,12,18]]},"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To explore the added value of hospital-registry data on invasive epithelial ovarian, tubal and peritoneal cancers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Historic cohort analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Unadjusted and adjusted regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Major South Australian hospitals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>1596 women (1984\u20132015 diagnoses).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>5-Year and 10-year survival was 48% and 41%, respectively, equivalent to relative survival for Australia and the USA. After adjusting for age, clinical and geographic factors, risk of ovarian cancer death was 25% lower in 2010\u20132015 than 1984\u20131989. Women generally had surgical treatment (87%) in their first round of care. This was more common for younger patients (adjusted OR (95% CIs) 0.17 (0.04 to 0.65) for 80+ vs &lt;40 years) and earlier International Federation of Gynecology and Obstetrics stages (adjusted OR 0.48 (0.13 to 1.78) for stage IIIB\/C and 0.13 (0.04 to 0.45) for stage IV vs stage IA). Most (74%) had systemic therapy, which was more common for advanced stages (adjusted ORs &gt;15.0 for stages III and IV vs stage IA). Few (9%) had radiotherapy. Women generally had systemic therapy (74%), without difference by service accessibility and socioeconomic disadvantage, suggesting equity. However, surgery was less common for residents of the most compared with least remote areas (adjusted OR 0.49 (0.24 to 0.99)); and more common prior to adjustment in the highest versus lowest socioeconomic category (unadjusted OR 1.55 (1.01 to 2.39)), but this elevation did not apply after adjustment (adjusted OR 0.19 (0.63 to 2.25)), with the difference largely explained by stage.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Hospital-registry data add value for assessing local service delivery. Equivalent survival to Australia-wide and USA survival, and temporal gains after adjusting for stage and other patient characteristics are reassuring. Survival gains may reflect therapeutic benefits of more extensive surgery and improved chemotherapy regimens.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2018-024036","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T09:25:16Z","timestamp":1549272316000},"page":"e024036","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the added value of hospital-registry data for showing local service outcomes: cancers of the ovary, fallopian tube and peritoneum"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6442-4409","authenticated-orcid":false,"given":"David","family":"Roder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Davy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sid","family":"Selva-Nayagam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sellvakumaran","family":"Paramasivam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqui","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy","family":"Keefe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9723-8047","authenticated-orcid":false,"given":"Caroline","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kellie","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianne","family":"Buranyi-Trevarton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin K","family":"Oehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,2,3]]},"reference":[{"key":"2024051714171897000_9.2.e024036.1","unstructured":"Ferlay J , Soerjomataram I , Ervik M , et al . GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. 2013 http:\/\/globocan.iarc.fr (accessed 6 Apr 2017)."},{"key":"2024051714171897000_9.2.e024036.2","unstructured":"Australian Institute of Health and Welfare (AIHW). Australian Cancer Incidence and Mortality (ACIM) books. Canberra: AIHW, 2013. http:\/\/www.aihw.gov.au\/acim-books\/ (Accessed 6 Apr 2017)."},{"key":"2024051714171897000_9.2.e024036.3","unstructured":"Australian Institute of Health and Welfare. Cancer in Australia 2017. Cancer Series no. 101. Cat. No. CAN 100. Canberra: AIHW, 2017."},{"key":"2024051714171897000_9.2.e024036.4","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw306"},{"key":"2024051714171897000_9.2.e024036.5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.5758"},{"key":"2024051714171897000_9.2.e024036.6","unstructured":"Australian Institute of Health and Welfare and Cancer Australia. Gynaecological cancers in Australia: an overview.\u00a0Cancer series no. 70. Cat. No. CAN 66. Canberra: AIHW, 2012."},{"key":"2024051714171897000_9.2.e024036.7","unstructured":"Howlader N , Noone AM , Krapcho M , et al . SEER Cancer Statistics Review, 1975-2014, National Cancer Institute. Bethesda, MD. based on November 2016 SEER data submission, posted to the SEER web site, April 2017 https:\/\/seer.cancer.gov\/csr\/1975_2014\/ (accessed 6 Apr 2017)."},{"key":"2024051714171897000_9.2.e024036.8","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000854"},{"key":"2024051714171897000_9.2.e024036.9","unstructured":"South Australian Cancer Registry. Epidemiology of cancer in South Australia. Incidence, Mortality and Survival 1977 to 1999. Issue 22, Cancer Series. Adelaide: South Australian Department of Health, 2000."},{"key":"2024051714171897000_9.2.e024036.10","unstructured":"Government of South Australia. South Australia: Health Care Act 2008 \u2013 Part 7. Version: 5.6. Adelaide: South Australian Government, 2017."},{"key":"2024051714171897000_9.2.e024036.11","unstructured":"Australian Institute of Health and Welfare, Cancer Australia & Australasian Association of Cancer Registries. Cancer survival and prevalence in Australia: cancers diagnosed from 1982 to 2004. Cancer Series no. 42\u00a0Cat. No. CAN 38. Canberra AIHW, 2008."},{"key":"2024051714171897000_9.2.e024036.12","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.7314\/APJCP.2015.16.6.2431","article-title":"Colorectal cancer treatment and survival: the experience of major public hospitals in South Australia over three decades","volume":"16","author":"Roder","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"2024051714171897000_9.2.e024036.13","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181577654"},{"key":"2024051714171897000_9.2.e024036.14","doi-asserted-by":"crossref","first-page":"556","DOI":"10.5694\/j.1326-5377.1988.tb93810.x","article-title":"Cancer case-survival rates for South Australia: a comparison with US rates and a preliminary investigation of time trends","volume":"148","author":"Bonett","year":"1988","journal-title":"Med J Aust"},{"key":"2024051714171897000_9.2.e024036.15","unstructured":"Armitage P , Berry G , Mathews JNS . Statistical methods in medical research. 2nd edn. Oxford, UK: Blackwell Scientific Publications, 1987."},{"key":"2024051714171897000_9.2.e024036.16","unstructured":"StataCorp LP. Stata Statistical Software. Release13. College Station, TX: StataCorp LP, 2014."},{"key":"2024051714171897000_9.2.e024036.17","unstructured":"South Australian Cancer Registry. Cancer in South Australia 2004 - with incidence projections to 2007. Adelaide: South Australian Department of Health, 2007."},{"key":"2024051714171897000_9.2.e024036.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2005.02127.x"},{"key":"2024051714171897000_9.2.e024036.19","unstructured":"Cancer Institute NSW. New South Wales Cancer Statistics. Sydney: Cancer Institute NSW. 2017 http:\/\/www.statistics.cancerinstitute.org.au\/ (accessed 6 April 2017)."},{"key":"2024051714171897000_9.2.e024036.20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.766"},{"key":"2024051714171897000_9.2.e024036.21","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0239"},{"key":"2024051714171897000_9.2.e024036.22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jogc.2016.10.006","article-title":"Endometrioid carcinoma of the ovary: outcomes compared to serous carcinoma after 10 years of follow-up","volume":"39","author":"Bouchard-Fortier","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"2024051714171897000_9.2.e024036.23","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e3181a3a436"},{"key":"2024051714171897000_9.2.e024036.24","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt333"},{"key":"2024051714171897000_9.2.e024036.25","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwr446"},{"key":"2024051714171897000_9.2.e024036.26","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.21873\/anticanres.11519","article-title":"Ovarian cancer surgery - a population-based registry study","volume":"37","author":"Leandersson","year":"2017","journal-title":"Anticancer Res"},{"key":"2024051714171897000_9.2.e024036.27","unstructured":"Cancer Australia. Improving Cancer Data Stage, Treatment and Recurrence (STAR). Sydney: Cancer Australia, 2017. https:\/\/canceraustralia.gov.au\/research-data\/cancer-data\/improving-cancer-data. (Accessed 6 Apr 2017)."},{"key":"2024051714171897000_9.2.e024036.28","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/ecc.12242","article-title":"Realising opportunities for evidence-based cancer service delivery and research: linking cancer registry and administrative data in Australia","volume":"23","author":"Roder","year":"2014","journal-title":"Eur J Cancer Care"},{"key":"2024051714171897000_9.2.e024036.29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5694\/mja14.00132","article-title":"Survival of Australian women with invasive epithelial ovarian cancer: a population-based study","volume":"201","author":"Anuradha","year":"2014","journal-title":"Med J Aust"},{"key":"2024051714171897000_9.2.e024036.30","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ygyno.2013.02.007","article-title":"Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer - a population-based study","volume":"129","author":"Jordan","year":"2013","journal-title":"Gynecol Oncol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-024036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:45:21Z","timestamp":1715993121000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-024036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1136\/bmjopen-2018-024036"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-024036","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}